Nanopath
Cambridge, US · Founded 2019 · Delaware corporation · 29 employees on LinkedIn · 7 known investors
Find your way into Nanopath
Nanopath is developing a molecular diagnostic platform for point-of-care disease diagnosis, with a focus on women's health. The company builds novel diagnostic technologies aimed at scalable, accessible testing.
Founders & leadership
Nanopath was founded in 2019 by Alison Burklund and Amogha Tadimety.
Board
AS
JC
Investors · 7
Norwest Venture PartnersMenlo Park · $10M – $30M
Service Provider CapitalVail
Gingerbread Capitalreported · 2 sourcesNew York · $100K – $10M
Medtech Convergencereported · 2 sourcesBoston
Norwich VenturesreportedWalthamvia Aaron Sandoski · board
SV Health InvestorsreportedBoston · $1M – $20M
Also in the syndicate · 1
Green D Ventures
Reported raises · per SEC filings
Form D private placements$15.3M disclosed across 2 rounds · 2022–2025
▶$5.3MraisedFeb 2025 · 5 investors · BiotechnologyRule 506(b)
▶$5.3MraisedFeb 2025 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alison BurklundExecutive Officer, Director
- Aaron SandoskiDirector
- Amogha TadimetyExecutive Officer, Director
- Jeff CroweDirector
- Offering amount
- $6M
- Amount sold
- $5.3M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedAug 2022 · 10 investors · BiotechnologyRule 506(b)
▶$10MraisedAug 2022 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey CroweDirector
- Alison BurklundExecutive Officer, Director
- Amogha TadimetyExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Nanopath do?
- Nanopath is developing a molecular diagnostic platform for point-of-care disease diagnosis, with a focus on women's health. The company builds novel diagnostic technologies aimed at scalable, accessible testing.
- Who founded Nanopath?
- Nanopath was founded by Alison Burklund, Amogha Tadimety in 2019.
- Who are Nanopath's investors?
- Nanopath's investors include Norwest Venture Partners, Service Provider Capital, Gingerbread Capital, Medtech Convergence, Norwich Ventures, SV Health Investors.
- How much funding has Nanopath raised?
- Nanopath has disclosed $15.3M raised across 2 rounds.
- Where is Nanopath headquartered?
- Nanopath is headquartered in Cambridge, US.